It is a chemicals private limited company based in Kolhapur, Maharashtra, India, established in 2014.
2014 | Kolhapur, Maharashtra, India | ActiveCross Berry Pharmaceuticals Private Limited, a active private limited company, was established on 13 February 2014 in Kolhapur, Maharashtra, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U33125PN2014PTC150609. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.24 M.
It upholds a compliant status. Its leadership includes Ashalata Deepak Wadakar (Director), Deepak Anandarao Wadkar (Director). Past directors included Deepak Anandarao Wadkar, Dipak Ekanath Shinde, Ramchandra Dattatray Barage. It holds ₹2.00 M open charges and ₹0.80 M settled loans. Its latest AGM occurred on 30 December 2020, with the balance sheet filed on 31 March 2020. It is based at 1016 Plot No 20 B Bhoite Nagar, Near Dugadha Cooperative Housing Society, Saneguruji, Vasahat, Kolhapur, Maharashtra, 416012.
U33125PN2014PTC150609
150609
13 February 2014
₹0.50 M
₹0.24 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Cross Berry Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashalata Deepak Wadakar | Director | 25 Feb 2021 | Current |
| Deepak Anandarao Wadkar | Director | 26 Jul 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 17 Apr 2019 | Past |
| Pramod Abcsdd | Director | 26 Feb 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cross Berry Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Cross Berry Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,000,000.00
₹800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jan 2022 | Others | ₹2.00 M | Open |
| 28 Dec 2017 | Bank Of India | ₹0.80 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Cross Berry Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cross Berry Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cross Berry Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 2.00 M with Charge ID 100529723 was registered on 21 Jan 2022. was recorded as a recent event.
A charge registered on 28 Dec 2017 via Charge ID 100150910 with Bank Of India was fully satisfied on 17 Jan 2022. was recorded as a recent event.
Ashalata Deepak Wadakar was appointed as a Director was appointed as a Director on 25 Feb 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.
Progress on Cross Berry Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Dec 2020 as per latest MCA records. was documented.
Cross Berry Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Pune. was recorded as a recent event.
The activity Deepak Anandarao Wadkar was appointed as a Director was appointed as a Director on 26 Jul 2019 & has been associated with this company since 6 years 4 months . was completed.
The CIN of Cross Berry Pharmaceuticals Private Limited is U33125PN2014PTC150609.
Cross Berry Pharmaceuticals Private Limited is headquartered at 1016 Plot No 20 B Bhoite Nagar, Near Dugadha Cooperative Housing Society, Saneguruji, Vasahat, Kolhapur, Maharashtra, 416012.
Cross Berry Pharmaceuticals Private Limited was incorporated on 13 February 2014.
The current directors of Cross Berry Pharmaceuticals Private Limited are
The primary industry of Cross Berry Pharmaceuticals Private Limited is Manufacturing.
Cross Berry Pharmaceuticals Private Limited is unlisted.
The authorized capital of Cross Berry Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.24 M.
The compliance status of Cross Berry Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX